KLK3 and metastatic prostate carcinoma: Doses of 10 mg lycopene/day administered for 3 months decreased PSA (Prostate Specific Antigen) level, tumor grade, bone pain, and urinary tract symptoms in patients with metastatic prostate cancer [19], interfering with growth factor receptor signaling and cell cycle progression [85].